WHO ICTRP trial
Long-Term Immune Persistence of attenuated varicella vaccine Injected two dose…
ChiCTR-OPC-14005347 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OPC-14005347 |
|---|---|
| Public title | Long-Term Immune Persistence of attenuated varicella vaccine Injected two dose among aged 13 to 17 years population |
| Scientific title | Long-Term Immune Persistence of attenuated varicella vaccine Injected two dose among aged 13 to 17 years population |
| Primary sponsor | Henan Centre for Disease Control and prevention |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Post-market |
| Countries | China |
| Conditions | Long-Term Immune Persistence of attenuated varicella vaccine |
| Interventions | Case series:injected two dose varicella vaccine |
| Registration date | Oct 16, 2014 |
| Target size | Case series:400 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: